These documents provide preclinical and clinical drug development and regulatory affairs departments with a substantial collection of comparative scientific and regulatory data that may not be included in final FDA Approval Package documents.

Center for Drug Evaluation and Research (CDER)

• Anesthetic and Life Support Drugs Advisory Committee
• Anti-Infective Drugs Advisory Committee
• Antiviral Drugs Advisory Committee
• Arthritis Drug Advisory Committee
• Cardiovascular and Renal Drugs Advisory Committee
• Dermatologic and Ophthalmic Drugs Advisory Committee
• Dermatologic Drugs Advisory Committee
• Drug Abuse Advisory Committee
• Drug Safety and Risk Management Advisory Committee
• Endocrinologic and Metabolic Drugs Advisory Committee
• Gastrointestinal Drugs Advisory Committee
• Medical Imaging Drugs Advisory Committee
• Nonprescription Drugs Advisory Committee
• Oncologic Drugs Advisory Committee
• Peripheral and Central Nervous System Drugs Advisory Committee
• Psychopharmacologic Drugs Advisory Committee
• Pulmonary-Allergy Drugs Advisory Committee
• Reproductive Health Drugs Advisory Committee

Center for Biologic Evaluation and Research (CBER)

• Vaccines and Related Biological Products Advisory Committee
• Allergenic Products Advisory Committe
• Blood Products Advisory Committe
• Cellular Tissue and Gene Therapies Advisory Committee

See Content Updates for the most recent content information.